Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
10/2008
10/30/2008WO2008131099A1 Biological agents active in central nervous system
10/30/2008WO2008130082A1 Tgfp-cap peptide and its uses
10/30/2008WO2008130053A1 Fused protein comprising protein g with avidin
10/30/2008WO2008129838A1 Germ cell marker using fish vasa gene
10/30/2008WO2008128345A1 ENGINEERED VERSIONS OF CGTB (β-1,3- GALACTOSYLTRANSFERASE) ENZYMES, WITH ENHANCED ENZYMATIC PROPERTIES
10/30/2008WO2008128330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008WO2008128329A1 Endotoxin removal
10/30/2008WO2008128289A1 Modified plant defensin
10/30/2008WO2008110653B1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof
10/30/2008WO2008095905A3 Pathogen binding
10/30/2008WO2008078177A3 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence
10/30/2008WO2007115723A8 Fusion proteins between plant cell-wall degrading enzymes and a swollenin, and their uses
10/30/2008US20080271167 for treatment of viral infection and nervous systtem disorders
10/30/2008US20080269151 Antigen, nucleic acid that encodes fusion protein; diagnosis, prevention, therapy of tuberculosis
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008US20080267871 Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide
10/30/2008CA2689481A1 Engineered versions of cgtb (.beta.-1,3-galactosyltransferase) enzymes, with enhanced enzymatic properties
10/30/2008CA2684575A1 Modified plant defensin
10/30/2008CA2684330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008CA2684328A1 Endotoxin removal
10/29/2008EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/29/2008EP1985701A2 Genes differentially expressed in breast cancer
10/29/2008EP1985630A2 T1R taste receptors and genes encoding same
10/29/2008EP1984503A1 Modified coagulation factor vila with extended half-life
10/29/2008EP1619208B1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein
10/29/2008EP1294771B1 Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
10/29/2008EP1234044B1 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides
10/29/2008EP1071460B1 INTERNALIZING ErbB2 ANTIBODIES
10/29/2008CN101294177A Method for preparing low molecular weight heparin
10/29/2008CN101294164A Expression of recombinant human metaphase factor (rh-Midkine), preparation and application of monoclone antibody
10/29/2008CN101293931A Anti-shrimp white spot syndrome virus recombined bacterium typhosum strain, preparation and uses thereof
10/29/2008CN101293099A Polypeptide vaccine for resisting multiple hypotype avian influenza viruses and preparation method thereof
10/29/2008CN100429234C Compounds and methods of early diagnosis of cervical cancer and genital condyloma with hpv, chsp60 tumor suppressor h-ras, k-ras and pten derived peptides modified
10/29/2008CN100429233C Recombinant solvent protein, its production and use
10/28/2008US7442784 For regulation of gene expression
10/28/2008US7442376 Glycoprotein hormone compositions containing two β subunits
10/28/2008US7442371 Recombinant human albumin-erythropoietin fusion proteins with long-lasting biological effects
10/28/2008CA2236948C Modified proteins and methods of their production
10/28/2008CA2225924C Recombinant mistletoe lectin
10/27/2008CA2586748A1 Agents for prophylaxis or treatment of neurological diseases and conditions
10/23/2008WO2008127179A1 Fusion protein vaccine
10/23/2008US20080263687 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
10/23/2008US20080262211 Hepatitis-c virus type 4, 5 and 6
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080260812 Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta)
10/23/2008US20080260780 Materials and methods relating to improved vaccination strategies
10/23/2008US20080260735 Glycoprotein-340 for use in targeted destruction of cancer tissues; immunotherapy
10/23/2008CA2684494A1 Fusion protein vaccine
10/23/2008CA2648864A1 Gene defects and mutant alk kinase in human solid tumors
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1981980A2 Methods and compositions for modifying plant biosynthetic pathways
10/22/2008EP1981914A2 Construction of new variants of dextransucrase dsr-s by genetic engineering
10/22/2008EP1532177B1 Immunomodulatory constructs and their uses
10/22/2008EP1311679B1 Method for inhibiting il-22 induced pap1
10/22/2008EP0833941B1 Polypeptides having a functional domain of interest and methods of identifying and using same
10/22/2008CN101292036A Method for the recombinant expression of a polypeptide
10/22/2008CN101291956A A peptide-immunoglobulin-conjugate
10/22/2008CN101291955A Non-activated polypeptides having a function of tissue regeneration and method for preparing the same
10/22/2008CN101289514A Process for cultivating stress-tolerant plants and special DNA fragments thereof
10/22/2008CN101289513A Detection of primary infections with pathogens
10/22/2008CN101289512A Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
10/22/2008CN101289511A Multivalent antibodies and uses therefore
10/22/2008CN100427600C Zoophobous fusion protein and use thereof
10/22/2008CN100427506C Process for preparation of polypeptides of interest from fusion polypeptides
10/21/2008US7439325 PRO6001 polypeptides
10/21/2008US7439320 Cripto tumour polypeptide
10/21/2008CA2387383C Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
10/21/2008CA2247998C Fragments of cr1 and their use
10/21/2008CA2232242C Long wavelength engineered fluorescent proteins
10/21/2008CA2042064C C-erbb-2 external domain:gp75
10/20/2008CA2626423A1 Detection of primary infections with pathogens
10/16/2008WO2008099178A3 Binding members for ige molecules
10/16/2008WO2008079270A3 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
10/16/2008US20080255344 Support comprising immobilized immunoglobulin for use in plasma pheresis in patients with sepsis or septic shock
10/16/2008US20080254031 Nucleotide sequences coding tumor antigens for use as diagnostic tool in detection and staging of cell proliferative disorders
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/15/2008EP1980615A1 Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell
10/15/2008EP1980573A2 Isolated dendritic cell membrane protein genes
10/15/2008EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/15/2008EP1233980B1 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
10/15/2008EP1151117B1 Intein-mediated protein ligation of expressed proteins
10/15/2008CN101287827A Amidases, nucleic acids encoding them and methods for making and using them
10/15/2008CN101287748A Compositions and methods for fusion protein separation
10/15/2008CN101287487A Agents and methods based on the use of the EDA domain of fibronectin
10/15/2008CN101287484A Binding agents which inhibit myostatin
10/15/2008CN101285066A Process for heterologously expressing and purifying human glucose transporters GLUT1, GLUT2 and GLUT3
10/15/2008CN101284877A Recombinant target fusion protein of antithrombin activity and anti-platelet aggregation and preparation method
10/15/2008CN101284876A Fusion protein Penharpin, preparation method and use
10/15/2008CN100425700C scFvC6.5-sTrail fusion gene and protein, and its preparation
10/15/2008CN100425699C scFvC6.5-TNF-alpha fusion gene and protein, and its preparation
10/14/2008US7435595 Using prokaryotic histone protein as tool in transfer of heterologus nucleotide sequences into cells; improving exogenous gene expression
10/14/2008US7435569 Method of forming a molded protein matrix for use in a sensor
10/14/2008US7435552 Binding assays that use human T1R2 to identify potential taste modulators
10/14/2008US7435410 Methods of treatment with interferson and albumin fusion protein
10/09/2008US20080250515 Polypeptide localization signal for enhancing bioavailability of drugs
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 295